Federal Deposit Insurance Corp. Chairman Martin Gruenberg said, in his testimony to the panel, that the failures of SVB, as Silicon Valley Bank is known, and Signature Bank “demonstrate the implications that banks with assets of $100 billion or more can have for financial stability
Symbiotec Pharmalab sets price band for Rs 1,757 crore IPO, to open on August 24
Symbiotec Pharmalab will launch its ₹1,757-crore IPO from August 24–27, 2026, with a price band of ₹938–988 per share. The minimum bid is 15 shares,